较高的邻居贫困与行为变异前性退行症的加速疾病进展有关
Rory Boyle1, Nadia Dehghani1, Sheina Emrani1
1Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alzheimer's & dementia. Behavior & socioeconomics of aging
|December 5, 2025
概括
邻居剥夺显著加速行为变异前退行症 (bvFTD) 的进展,并缩短生存期. 这凸显了影响bvFTD预后的社会经济差异.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 社区贫困与不良健康结果有关,包括认知能力下降和老化中的神经退行以及阿尔茨海默病.
- 社区贫困对行为变异前退行症 (bvFTD) 的进展的影响仍未得到研究.
研究的目的:
- 调查邻里贫困和bvFTD患者的疾病进展之间的联系.
- 确定社会经济因素是否影响bvFTD患者的生存率和认知衰退.
主要方法:
- 该研究分析了311名临床诊断为bvFTD的个体的数据.
- 使用区域贫困指数 (ADI) 来评估邻里贫困情况.
- 研究人员检查了ADI和生存之间的关联,以及认知 (全球,执行功能,语言) 的纵向变化.
主要成果:
- 在最贫困地区的个人在症状发作后的生存时间比较短,而不是在较不贫困地区的人.
- 在来自贫困社区的个人中,全球认知,执行功能和语言的下降速度更快.
- 无论遗传风险因素如何,这些关联仍然显著.
结论:
- 更高的社区贫困与bvFTD的加速疾病过程有关.
- 社会经济差异显著影响bvFTD的预后和进展.
- 调查结果强调了在管理bvFTD时需要解决社会经济因素的需要.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Human Genetics
1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764


